Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Koch–Henriksen N[au]:

The changing demographic pattern of multiple sclerosis epidemiology. Koch-Henriksen N et al. Lancet Neurol. (2010)

Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study. Nielsen NM et al. Neurology. (2017)

The Danish Multiple Sclerosis Treatment Register. Magyari M et al. Clin Epidemiol. (2016)

Search results

Items: 1 to 50 of 132

1.

The population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.

Papp V, Iljicsov A, Rajda C, Magyari M, Koch-Henriksen N, Petersen T, Jakab G, Deme I, Nagy F, Imre P, Lohner Z, Kovács K, Birkás AJ, Köves Á, Rum G, Nagy Z, Kerényi L, Vécsei L, Bencsik K, Jobbágy Z, Diószeghy P, Horváth L, Galántai G, Kasza J, Molnár G, Simó M, Sátori M, Rózsa C, Ács P, Berki T, Lovas G, Komoly S, Illes Z.

Eur J Neurol. 2019 Aug 29. doi: 10.1111/ene.14079. [Epub ahead of print]

PMID:
31465603
2.

Changes in the sex ratio are a good indicator of changes in MS incidence - No.

Magyari M, Koch-Henriksen N.

Mult Scler. 2019 May 15:1352458519837926. doi: 10.1177/1352458519837926. [Epub ahead of print] No abstract available.

PMID:
31088314
3.

Multiple sclerosis among first- and second-generation immigrants in Denmark: a population-based cohort study.

Munk Nielsen N, Corn G, Frisch M, Stenager E, Koch-Henriksen N, Wohlfahrt J, Magyari M, Melbye M.

Brain. 2019 Jun 1;142(6):1587-1597. doi: 10.1093/brain/awz088.

PMID:
31081503
4.

Worsening of disability caused by relapses in multiple sclerosis: A different approach.

Koch-Henriksen N, Thygesen LC, Sørensen PS, Magyari M.

Mult Scler Relat Disord. 2019 Jul;32:1-8. doi: 10.1016/j.msard.2019.04.017. Epub 2019 Apr 15.

PMID:
31003200
5.

Author response: Incidence of MS has increased markedly over 6 decades in Denmark particularly with late onset and in women.

Koch-Henriksen N.

Neurology. 2019 Feb 19;92(8):397. doi: 10.1212/WNL.0000000000006944. No abstract available.

PMID:
30777918
6.

The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis.

Hasselbalch IC, Søndergaard HB, Koch-Henriksen N, Olsson A, Ullum H, Sellebjerg F, Oturai AB.

Mult Scler J Exp Transl Clin. 2018 Nov 28;4(4):2055217318813183. doi: 10.1177/2055217318813183. eCollection 2018 Oct-Dec.

7.

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

Papp V, Illes Z, Magyari M, Koch-Henriksen N, Kant M, Pfleger CC, Roemer SF, Jensen MB, Petersen AE, Nielsen HH, Rosendahl L, Mezei Z, Christensen T, Svendsen K, Hyldgaard Jensen PE, Lydolph MC, Heegaard N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T.

Neurology. 2018 Dec 11;91(24):e2265-e2275. doi: 10.1212/WNL.0000000000006645. Epub 2018 Nov 9.

8.

Early versus later treatment start in multiple sclerosis: a register-based cohort study.

Chalmer TA, Baggesen LM, Nørgaard M, Koch-Henriksen N, Magyari M, Sorensen PS; Danish Multiple Sclerosis Group.

Eur J Neurol. 2018 Oct;25(10):1262-e110. doi: 10.1111/ene.13692. Epub 2018 Jul 9.

PMID:
29847005
9.

Infections seem to be more frequent before onset of pediatric multiple sclerosis: A Danish nationwide nested case-control study.

Boesen MS, Koch-Henriksen N, Thygesen LC, Eriksson F, Greisen G, Born AP, Blinkenberg M, Uldall PV, Magyari M.

Mult Scler. 2019 May;25(6):783-791. doi: 10.1177/1352458518771871. Epub 2018 May 17.

PMID:
29770725
10.

Small-scale geographical variation in multiple sclerosis: A case-control study using Danish register data 1971-2013.

Bihrmann K, Nielsen NM, Magyari M, Koch-Henriksen N, Nordsborg RB, Ersbøll AK.

Mult Scler Relat Disord. 2018 Jul;23:40-45. doi: 10.1016/j.msard.2018.04.021. Epub 2018 May 4.

11.

Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: a nationwide validation study.

Boesen MS, Blinkenberg M, Koch-Henriksen N, Thygesen LC, Uldall PV, Magyari M, Born AP.

Dev Med Child Neurol. 2018 Nov;60(11):1123-1131. doi: 10.1111/dmcn.13798. Epub 2018 May 10.

PMID:
29744874
12.

Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women.

Koch-Henriksen N, Thygesen LC, Stenager E, Laursen B, Magyari M.

Neurology. 2018 May 29;90(22):e1954-e1963. doi: 10.1212/WNL.0000000000005612. Epub 2018 May 2.

PMID:
29720546
13.

Smoking affects the interferon beta treatment response in multiple sclerosis.

Petersen ER, Oturai AB, Koch-Henriksen N, Magyari M, Sørensen PS, Sellebjerg F, Søndergaard HB.

Neurology. 2018 Feb 13;90(7):e593-e600. doi: 10.1212/WNL.0000000000004949. Epub 2018 Jan 17.

PMID:
29343473
14.

Psychiatric morbidity develops after onset of pediatric multiple sclerosis: A Danish nationwide population-based study.

Boesen MS, Thygesen LC, Uldall PV, Eriksson F, Born AP, Blinkenberg M, Koch-Henriksen N, Greisen G, Magyari M.

Mult Scler Relat Disord. 2018 Jan;19:30-34. doi: 10.1016/j.msard.2017.10.018. Epub 2017 Oct 31.

PMID:
29121513
15.

Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.

Thormann A, Sørensen PS, Koch-Henriksen N, Laursen B, Magyari M.

Neurology. 2017 Oct 17;89(16):1668-1675. doi: 10.1212/WNL.0000000000004508. Epub 2017 Sep 20.

PMID:
28931645
16.

Dietary sodium intake: An etiologic dead end in multiple sclerosis.

Koch-Henriksen N, Lauer K.

Neurology. 2017 Sep 26;89(13):1314-1315. doi: 10.1212/WNL.0000000000004426. Epub 2017 Aug 25. No abstract available.

PMID:
28842448
17.

Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study.

Koch-Henriksen N, Laursen B, Stenager E, Magyari M.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):626-631. doi: 10.1136/jnnp-2017-315907.

PMID:
28705951
18.

Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: A nationwide population-based incidence study.

Boesen MS, Magyari M, Koch-Henriksen N, Thygesen LC, Born AP, Uldall PV, Blinkenberg M.

Mult Scler. 2018 Jul;24(8):1077-1086. doi: 10.1177/1352458517713669. Epub 2017 Jun 13.

PMID:
28608742
19.

Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships.

Thormann A, Sørensen PS, Koch-Henriksen N, Thygesen LC, Laursen B, Magyari M.

Eur J Neurol. 2017 Jun;24(6):825-834. doi: 10.1111/ene.13297.

PMID:
28544411
20.

Age at Menarche and Risk of Multiple Sclerosis: A Prospective Cohort Study Based on the Danish National Birth Cohort.

Nielsen NM, Harpsøe M, Simonsen J, Stenager E, Magyari M, Koch-Henriksen N, Baker JL, Hjalgrim H, Frisch M, Bager P.

Am J Epidemiol. 2017 Apr 15;185(8):712-719. doi: 10.1093/aje/kww160.

PMID:
28369233
21.

Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort.

Thormann A, Koch-Henriksen N, Laursen B, Sørensen PS, Magyari M.

Mult Scler Relat Disord. 2016 Nov;10:181-186. doi: 10.1016/j.msard.2016.10.008. Epub 2016 Oct 29.

PMID:
27919487
22.

Early safety and efficacy of fingolimod treatment in Denmark.

Voldsgaard A, Koch-Henriksen N, Magyari M, Sellebjerg F, Sørensen PS, Oturai AB.

Acta Neurol Scand. 2017 Jan;135(1):129-133. doi: 10.1111/ane.12573. Epub 2016 Mar 8.

PMID:
27910101
23.

Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A.

Neurology. 2017 Jan 3;88(1):44-51. doi: 10.1212/WNL.0000000000003454. Epub 2016 Nov 30.

24.

The Danish Multiple Sclerosis Treatment Register.

Magyari M, Koch-Henriksen N, Sørensen PS.

Clin Epidemiol. 2016 Oct 25;8:549-552. eCollection 2016. Review.

25.

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.

Bachelet D, Hässler S, Mbogning C, Link J, Ryner M, Ramanujam R, Auer M, Hyldgaard Jensen PE, Koch-Henriksen N, Warnke C, Ingenhoven K, Buck D, Grummel V, Lawton A, Donnellan N, Hincelin-Mery A, Sikkema D, Pallardy M, Kieseier B, Hemmer B, Hartung HP, Soelberg Sorensen P, Deisenhammer F, Dönnes P, Davidson J, Fogdell-Hahn A, Broët P; ABIRISK Consortium.

PLoS One. 2016 Nov 2;11(11):e0162752. doi: 10.1371/journal.pone.0162752. eCollection 2016.

26.

Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Thormann A, Magyari M, Koch-Henriksen N, Laursen B, Sørensen PS.

J Neurol. 2016 Dec;263(12):2484-2493. Epub 2016 Oct 3.

PMID:
27699465
27.

Employment, disability pension and income for children with parental multiple sclerosis.

Moberg JY, Laursen B, Koch-Henriksen N, Thygesen LC, Brødsgaard A, Soelberg Sørensen P, Magyari M.

Mult Scler. 2017 Jul;23(8):1148-1156. doi: 10.1177/1352458516672016. Epub 2016 Sep 28.

PMID:
27682230
28.

Educational achievements of children of parents with multiple sclerosis: A nationwide register-based cohort study.

Moberg JY, Magyari M, Koch-Henriksen N, Thygesen LC, Laursen B, Soelberg Sørensen P.

J Neurol. 2016 Nov;263(11):2229-2237. Epub 2016 Aug 19.

PMID:
27541043
29.

A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.

Koch-Henriksen N, Magyari M, Sellebjerg F, Soelberg Sørensen P.

Mult Scler. 2017 Feb;23(2):234-241. doi: 10.1177/1352458516643393. Epub 2016 Jul 11.

PMID:
27055806
30.

Self-rated health in women prior to clinical onset of multiple sclerosis: A study within the Danish National Birth Cohort.

Nielsen NM, Harpsøe MC, Simonsen J, Stenager E, Magyari M, Koch-Henriksen N, Frisch M, Bager P.

Mult Scler. 2016 Oct;22(11):1444-1451. Epub 2016 Jan 8.

PMID:
26746810
31.

Physical and social environment and the risk of multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS.

Mult Scler Relat Disord. 2014 Sep;3(5):600-6. doi: 10.1016/j.msard.2014.07.002. Epub 2014 Jul 21.

PMID:
26265272
32.

Registers of multiple sclerosis in Denmark.

Koch-Henriksen N, Magyari M, Laursen B.

Acta Neurol Scand. 2015;132(199):4-10. doi: 10.1111/ane.12424. Review.

PMID:
26046552
33.

Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis.

Laursen JH, Søndergaard HB, Albrechtsen A, Frikke-Schmidt R, Koch-Henriksen N, Soelberg Sørensen P, Sellebjerg F, Oturai A.

Mult Scler. 2015 Oct;21(11):1414-22. doi: 10.1177/1352458514563590. Epub 2014 Dec 22.

PMID:
25533295
34.

Gender effects on treatment response to interferon-beta in multiple sclerosis.

Magyari M, Koch-Henriksen N, Laursen B, Sørensen PS.

Acta Neurol Scand. 2014 Dec;130(6):374-9. doi: 10.1111/ane.12277. Epub 2014 Sep 10.

PMID:
25208455
35.

The use of valproic acid and multiple sclerosis.

Nielsen NM, Svanström H, Stenager E, Magyari M, Koch-Henriksen N, Pasternak B, Hviid A.

Pharmacoepidemiol Drug Saf. 2015 Mar;24(3):262-8. doi: 10.1002/pds.3692. Epub 2014 Aug 11.

PMID:
25111895
36.

Prediction of response to interferon therapy in multiple sclerosis.

Sellebjerg F, Søndergaard HB, Koch-Henriksen N, Sørensen PS, Oturai AB.

Acta Neurol Scand. 2014 Oct;130(4):268-75. doi: 10.1111/ane.12269. Epub 2014 Jun 18.

PMID:
24943672
37.

Multiple sclerosis registries in Europe - results of a systematic survey.

Flachenecker P, Buckow K, Pugliatti M, Kes VB, Battaglia MA, Boyko A, Confavreux C, Ellenberger D, Eskic D, Ford D, Friede T, Fuge J, Glaser A, Hillert J, Holloway E, Ioannidou E, Kappos L, Kasilingam E, Koch-Henriksen N, Kuhle J, Lepore V, Middleton R, Myhr KM, Orologas A, Otero S, Pitschnau-Michel D, Rienhoff O, Sastre-Garriga J, Schyns-Liharska T, Sutovic D, Thalheim C, Trojano M, Vlasov YV, Yaldizli O; EUReMS Consortium.

Mult Scler. 2014 Oct;20(11):1523-32. doi: 10.1177/1352458514528760. Epub 2014 Apr 28.

PMID:
24777278
38.

Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients.

Sorensen PS, Koch-Henriksen N, Petersen T, Ravnborg M, Oturai A, Sellebjerg F.

J Neurol. 2014 Jun;261(6):1170-7. doi: 10.1007/s00415-014-7325-8. Epub 2014 Apr 12.

PMID:
24728334
39.

Stressful life-events in childhood and risk of multiple sclerosis: a Danish nationwide cohort study.

Nielsen NM, Pedersen BV, Stenager E, Koch-Henriksen N, Frisch M.

Mult Scler. 2014 Oct;20(12):1609-15. doi: 10.1177/1352458514528761. Epub 2014 Mar 31.

PMID:
24687805
40.

Major stressful life events in adulthood and risk of multiple sclerosis.

Nielsen NM, Bager P, Simonsen J, Hviid A, Stenager E, Brønnum-Hansen H, Koch-Henriksen N, Frisch M.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1103-8. doi: 10.1136/jnnp-2013-307181. Epub 2014 Mar 7.

PMID:
24610940
41.

Gender and autoimmune comorbidity in multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS.

Mult Scler. 2014 Aug;20(9):1244-51. doi: 10.1177/1352458514521515. Epub 2014 Feb 5.

PMID:
24500604
42.

Alternative data sources for estimating multiple sclerosis prevalence.

Koch-Henriksen N.

Mult Scler. 2013 Nov;19(13):1682-3. doi: 10.1177/1352458513511879. No abstract available.

PMID:
24218485
43.

Multiple sclerosis and risk of Parkinson's disease: a Danish nationwide cohort study.

Nielsen NM, Pasternak B, Stenager E, Koch-Henriksen N, Frisch M.

Eur J Neurol. 2014;21(1):107-11. doi: 10.1111/ene.12255. Epub 2013 Sep 19.

PMID:
24053187
44.

The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

Møller M, Søndergaard HB, Koch-Henriksen N, Sorensen PS, Sellebjerg F, Oturai AB.

Acta Neurol Scand. 2014 Jan;129(1):27-31. doi: 10.1111/ane.12145. Epub 2013 May 14.

PMID:
23668375
45.

Socioeconomic factors in childhood and the risk of multiple sclerosis.

Nielsen NM, Jørgensen KT, Bager P, Stenager E, Pedersen BV, Hjalgrim H, Koch-Henriksen N, Frisch M.

Am J Epidemiol. 2013 Jun 1;177(11):1289-95. doi: 10.1093/aje/kws350. Epub 2013 May 9.

PMID:
23660795
46.

Childhood body mass index and multiple sclerosis risk: a long-term cohort study.

Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sørensen TI, Baker JL.

Mult Scler. 2013 Sep;19(10):1323-9. doi: 10.1177/1352458513483889. Epub 2013 Apr 2.

47.

Reproduction and the risk of multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS.

Mult Scler. 2013 Oct;19(12):1604-9. doi: 10.1177/1352458513481397. Epub 2013 Mar 18.

PMID:
23508651
48.

Cesarean section and offspring's risk of multiple sclerosis: a Danish nationwide cohort study.

Nielsen NM, Bager P, Stenager E, Pedersen BV, Koch-Henriksen N, Hjalgrim H, Frisch M.

Mult Scler. 2013 Oct;19(11):1473-7. doi: 10.1177/1352458513480010. Epub 2013 Mar 6.

PMID:
23466398
49.

A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.

Galea I, Lederer C, Neuhaus A, Muraro PA, Scalfari A, Koch-Henriksen N, Heesen C, Koepke S, Stellmann P, Albrecht H, Winkelmann A, Weber F, Bahn E, Hauser M, Edan G, Ebers G, Daumer M.

Eur J Neurol. 2013 Jul;20(7):1107-9. doi: 10.1111/ene.12016. Epub 2012 Dec 7.

50.

Treatment of HIV and risk of multiple sclerosis.

Nexø BA, Pedersen L, Sørensen HT, Koch-Henriksen N.

Epidemiology. 2013 Mar;24(2):331-2. doi: 10.1097/EDE.0b013e318281e48a. No abstract available.

PMID:
23377093

Supplemental Content

Loading ...
Support Center